Omthera Pharmaceuticals, Inc.

๐Ÿ“ Princeton, United States๐Ÿ—“ Founded 2008๐Ÿ‘ฅ 2 employees๐Ÿ’ฐ Last funded 2011
Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Omthera Pharmaceuticals, Inc.?
Omthera Pharmaceuticals, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did Omthera Pharmaceuticals, Inc. last raise funding?
The most recent investment in Omthera Pharmaceuticals, Inc. recorded on gritt.io was in 2011.
When was Omthera Pharmaceuticals, Inc. founded?
Omthera Pharmaceuticals, Inc. was founded in 2008.
What industry is Omthera Pharmaceuticals, Inc. in?
Omthera Pharmaceuticals, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Omthera Pharmaceuticals, Inc. based?
Omthera Pharmaceuticals, Inc. is headquartered in Princeton, United States.